Hemophilia B Gene Therapy AMT-060 Moves to Large-scale Production, Says UniQure – Hemophilia News Today
|
Hemophilia B Gene Therapy AMT-060 Moves to Large-scale Production, Says UniQure
Hemophilia News Today Pharmaceutical firm uniQure N.V. has developed an optimized large-scale process to manufacture its lead gene, therapydate, to treat hemophilia B. This new platform will allow the Dutch company to boost production of its AMT-060 gene therapy at its … |
